Administration of the novel Flt3 inhibitor, crenolanib, in conjunction with intensive chemotherapy, results in high response rates with acceptable toxicity supporting its current evaluation in a ...
Turnaround time for initial testing is longer (4-6 weeks) but is 7-10 days for subsequent testing. Tumor-agnostic assays have the advantage of rapid turnaround time (7-10 days) promoting precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results